Abdul Mannan: Pencil Cells in IDA – Why Most, but Not All Cases Show Them
Abdul Mannan, Consultant Haematologist at Betsi Cadwaladr University Health Board, shared a post on LinkedIn:
“‘I asked myself a question this week: why do pencil cells appear in most IDA cases but not all? The answer is more interesting than I expected.’
Most haematology trainees think pencil cells are equal to iron deficiency.
That is only half the story.
I looked at this properly this week — grounded literature search, real papers, no shortcuts.
Here is what the evidence actually says:
Pencil cells (elongated elliptocytes) appear in iron deficiency because low haemoglobin content changes how the red cell behaves under shear stress in the microcirculation. But the mechanism is genuinely debated.
Yip and Mohandas (Blood, 1983) found increased membrane stiffness from oxidative damage.
Reinhart (BJH, 1992) found the opposite — membrane elasticity is preserved and the cells actually pass more easily through narrow pores because of microcytosis.
Red cells live 120 days. Early iron deficiency means old, normally-shaped cells are still circulating. The film looks unremarkable. Biochemistry is already abnormal.
Severe hypochromia matters more than microcytosis alone. A patient with MCH of 18 pg shows pencil cells. One with MCH of 24 pg often does not.
Thalassaemia trait, anaemia of chronic disease, or partial treatment all suppress pencil cell formation even when IDA is present
Ford (Int J Lab Haematol, 2013) put it directly: the classic blood film appearances in iron deficiency are unreliable in practice.
So the teaching point is this.
Absence of pencil cells never excludes IDA. Their presence tells you something has been going on long enough, severely enough, for the circulating pool to turn over.
Stage. Severity. Duration. Concurrent conditions. That is why not all IDA films look the same.
What morphological finding has surprised you most in a confirmed IDA case?”
Other posts featuring Abdul Mannan on Hemostasis Today.
-
Jun 7, 2026, 18:25Nita Radhakrishnan: Every Child Cured Is a Reminder of What Can Be Achieved When We Work Together
-
Jun 7, 2026, 18:24Yvette Fairfax: Wiskott-Aldrich Gene Therapy Changes Immunity, but Affordability May Determine Survival
-
Jun 7, 2026, 18:21Gulab Makwana: Complete Guide to Clotting Factors – Understanding the Coagulation System
-
Jun 7, 2026, 18:15Chuhan Dong: Presenting My Research on Antibody-Mediated RBC Clearance at Canadian Blood Services
-
Jun 7, 2026, 16:12Amr Mohamed: Common Types of Anemia
-
Jun 7, 2026, 15:50Venkateshwarlu Bairi: AVEVA Hyderabad Supports Children Living with Thalassemia and Sickle Cell Conditions
-
Jun 7, 2026, 15:48José Antonio García Erce: Hemochromatosis and Blood Donation
-
Jun 7, 2026, 15:29Marc Scherlinger: Uncovering the Immuno-Inflammatory Functions of Platelets at EULAR 2026
-
Jun 7, 2026, 15:18Huyen Nguyen: Highlights from the NCCN Cancer-Associated Venous Thromboembolic Disease Guidelines